Name

MSA Partners

Legal name

MSAPR Partners

Website

https://msapr.com

Company type

Private

Founded year

1983

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Market Intelligence & Cross-Border Business Consulting

NAICS

Marketing Research and Public Opinion Polling (541910), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

B2B / Industrial Market Research (MPAAALAA)

Keywords

• Pharmaceutical market intelligence
• Biotech industry research
• Cross-border consulting
• Japanese business consulting
• Regulatory intelligence services

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Beikoku Seiyaku Gyokai Shuho (US Pharmaceutical Industry Weekly Report): Weekly publication covering regulatory and industry developments in the US pharmaceutical market, published in Japanese. Delivered as PDF via email every Friday evening. Sold as annual subscription with 48 issues per year. Subscribers include all of Japan's largest pharmaceutical and life sciences companies.
2. Beikoku Bio Gyokai Geppo (US Bio Industry Monthly Report): Monthly report covering developments in the US biotech industry. Each issue includes feature articles, interviews, and sections on licensing, venture capital, M&A, IPOs, and stock market movements. Sold as annual subscription with 12 issues per year.
3. Blue Moose Research (Customized Reports): Boutique research division providing customized reports on select topics. Reports cover US healthcare legislation, biosimilars, pharmaceutical distribution, and other timely topics. Created on client request basis.
4. Consulting and Advisory Services: Research and consulting services including gathering and analyzing information about US regulations, corporations, and industries. Also includes conducting interviews with key opinion leaders and facilitating B2B relationships for Japanese companies.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

MSA Partners publishes Japanese-language market intelligence on the US pharmaceutical and biotech industries and provides research, consulting, business-to-business facilitation, and communications support services to Japanese companies operating in or entering the US market. Its flagship offerings are the Beikoku Seiyaku Gyokai Shuho (US Pharmaceutical Industry Weekly Report) and the Beikoku Bio Gyokai Geppo (US Bio Industry Monthly Report), complemented by customized research via its Blue Moose Research division and consulting/advisory engagements.

Product overview

MSA Partners is a consulting and research services firm that operates a portfolio of Japanese-language publications and professional services for Japanese companies doing business in the U.S. The core offerings include two regular publications: the Beikoku Seiyaku Gyokai Shuho (U.S. Pharmaceutical Industry Weekly Report), a weekly publication covering FDA regulations and pharma/biotech industry news, and the Beikoku Bio Gyokai Geppo (U.S. Bio Industry Monthly Report), a monthly biotech industry digest. Supporting these publications is the Blue Moose Research division providing customized reports, alongside three service lines: B2B Facilitation Services (partner identification and market entry support), Research & Consulting Services (regulatory and industry analysis), and Communications Support Services (language bridge and training). The company also maintains a subscriber-only online archive system for accessing back issues of the weekly report.

Differentiator

Problem solved

Functional benefit

Brands

• Beikoku Seiyaku Gyokai Shuho (U.S. Pharmaceutical Industry Weekly Report): Weekly report covering regulatory and industry developments in the U.S. pharmaceutical market published in Japanese.
• Beikoku Bio Gyokai Geppo (U.S. Bio Industry Monthly Report)
• Blue Moose Research

Products and services

• Beikoku Seiyaku Gyokai Shuho (U.S. Pharmaceutical Industry Weekly Report) Weekly Japanese-language report covering regulatory and industry developments in the U.S. pharmaceutical market. Each issue includes a feature article, an interview article (with pharma/biotech executives, government officials, medical and legal experts), and news sections on regulatory, company, biotech, and research developments. Sold as an annual subscription (48 issues/year) to corporate subscribers including all of Japan's largest pharmaceutical and life sciences companies.
• Beikoku Bio Gyokai Geppo (U.S. Bio Industry Monthly Report) Monthly Japanese-language report covering developments in the U.S. biotech industry. Each issue includes a feature article, an original interview, and four additional sections covering licensing, venture capital, mergers and acquisitions/IPOs/secondary offerings, and stock market movements. Sold as an annual subscription (12 issues/year) to Japan's largest pharmaceutical and other life sciences companies.
• Blue Moose Research (Customized Reports) Boutique research division at MSA providing customized reports on select topics on a client-request basis. Topics include US healthcare legislation, biosimilars, pharmaceutical distribution, and other timely issues. Tailored to specific client business needs.
• Business-to-Business Facilitation Services Service helping Japanese companies in a variety of industries assess the US market, identify potential partner companies, and initiate relationships. Targets Japanese-headquartered organizations seeking US market entry or expansion support.
• Research & Consulting Services Service gathering and analyzing information about US regulations, corporations, and industries, including conducting interviews with key opinion leaders (executives, researchers, government officials). Sold to Japanese companies needing in-depth US regulatory and industry analysis beyond the standard publications.
• Communications Support Services Service supporting and enhancing communication flow between Japanese-speaking and English-speaking offices or departments at global companies by reducing the Japanese/English language barrier. Includes conducting seminars and Q&A sessions for employees and executives.

Quantifiable outcome

• Corporate subscribers include all of Japan's largest pharmaceutical and life sciences companies

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves6 records

Expansion highlights3 records

Broad incumbents

• GlobalData Pharmaceutical: Global market research and consulting firm with a dedicated pharma practice covering pipelines, deals, and regulatory trends. Overlaps with MSA's custom research and consulting offerings, though GlobalData is far broader and more enterprise-software-led.
• Citeline (Informa Pharma Intelligence): Informa's pharma intelligence arm offering deep global coverage of drug development, regulatory, clinical trial, and deal data. Comparable to MSA as a subscription-based pharma intelligence provider, though at vastly larger scale and broader geographic scope.
• IQVIA: Global provider of pharma analytics, market intelligence, and commercial consulting. Touches MSA's territory through pharma market insights and Japan-US commercial advisory work, but at vastly larger scale with proprietary data assets.
• ZS Associates: Global management consulting firm with deep pharma and life sciences practice including commercial strategy and Japan market entry work. Overlaps with MSA's Research & Consulting and B2B Facilitation offerings for Japanese pharma clients.
• Norstella (EvaluatePharma): Pharma and biotech commercial intelligence platform offering forecasts, deal data, and industry analysis. Comparable to MSA's monthly Beikoku Bio Geppo for licensing, venture capital, M&A, and IPO coverage of US biotech.

Direct peers

• Intralink: Cross-border business development consultancy that helps Japanese and other Asian technology and life sciences companies expand into Western markets. Comparable to MSA's B2B Facilitation Services and Communications Support Services for Japanese pharma entering the US.
• BioCentury: Independent biotech industry intelligence and analysis publisher with weekly publications and custom research. Closely comparable to MSA's Beikoku publications in format (weekly features, deal coverage, executive interviews) and buyer profile (biopharma strategy teams).

Regional players

• JETRO (Japan External Trade Organization): Japanese government-affiliated trade promotion organization supporting Japanese companies expanding overseas, including into the US. Partially overlaps with MSA's mission of helping Japanese companies succeed in the US, though JETRO is a non-profit public entity spanning all industries.

Emerging players

• Fierce Pharma: Pharma industry news and analysis outlet covering US drug development, regulatory, and commercial news. Comparable to the news-coverage portion of MSA's weekly publication, though distributed freely online rather than as a paid Japanese-language subscription.
• Pharma Japan / PharmaBoardroom: Industry publications providing interviews, analysis, and country-level coverage of pharmaceutical markets including Japan-US cross-border activity. Partial overlap with MSA's executive interview content and bilingual market intelligence positioning.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/msa-partners

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MSA Partners